News

Investors' Class Action Opportunity Against Easterly ROCMuni Fund

Investors' Class Action Opportunity Against Easterly ROCMuni Fund

Opportunities for Investors in the Easterly ROCMuni Fund

The Schall Law Firm has recently informed investors about their option to file a class action lawsuit against the Easterly ROCMuni High Income Municipal Bond Fund (ticker RMJAX). Investigations have raised concerns about the Fund’s compliance with federal securities laws.

If you are someone who invested in the Fund's securities during the period of May 5, 2023, to June 12, 2025, you may be eligible to participate in this legal pursuit for justice. The lawsuit aims to address various misleading statements made by the Fund concerning its portfolio valuations and overall performance.

Understanding the Allegations Against the Fund

According to the recent complaint, it is alleged that the Easterly ROCMuni Fund conducted itself in a misleading manner by reporting inflated asset values. These inflated valuations gave investors a false sense of the stability and performance of their investments. Moreover, even though the Fund claimed to manage a diverse array of assets, it was heavily invested in illiquid securities, raising serious questions about its valuation methods.

This overstatement of the net asset value (NAV) and its reported performance led to significant damages for investors once the truth began to surface in the market. As the status of these issues gained traction, investors became more aware of the substantial discrepancies between reported values and the actual market situation.

Actions Available for Affected Investors

Investors affected by this situation are encouraged to connect with the Schall Law Firm for further assistance in understanding their potential claims. It is crucial for individuals who have suffered losses to reach out before the deadline for filing claims. Currently, the class action has yet to receive formal certification, leaving investors at a crossroads concerning their next steps.

Those who believe they may be eligible to join this lawsuit should consider contacting the firm to assess their rights. It’s a significant opportunity for investors to hold the Fund accountable for the allegations of misconduct.

The Role of the Schall Law Firm

The Schall Law Firm, recognized for its expertise in securities class action lawsuits, represents a global clientele of investors seeking justice in matters like these. Their mission is to uphold the rights of shareholders and ensure every investor can seek recourse for financial damages incurred from negligent or deceptive practices.

Investors can rest assured that contacting the firm for guidance is free of charge. Representatives at the Firm are prepared to discuss the particulars of your situation and explore possible legal avenues to recover your losses.

Frequently Asked Questions

What is the Easterly ROCMuni Fund lawsuit about?

The lawsuit addresses allegations of securities fraud against the Easterly ROCMuni High Income Municipal Bond Fund due to misleading statements and inflated asset valuations.

Who can join the class action against the Easterly ROCMuni Fund?

Any investor who purchased the Fund's securities between May 5, 2023, and June 12, 2025, may be eligible to join the class action.

How can I participate in the lawsuit?

Affected investors should contact the Schall Law Firm before the participation deadline to learn more about their eligibility and the claims process.

What is the deadline for joining the class action?

The deadline for participating in the class action lawsuit is September 22, 2025.

Is there a cost involved in contacting the Schall Law Firm?

No, consulting with the Schall Law Firm is free, allowing investors to understand their rights without financial obligations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Excellence: The 2025 Audio Description Awards Gala

Updated Category News Views 181

Join the Celebration at the 2025 Audio Description Awards Gala The American Council of the Blind (ACB) warmly invites everyone to participate in the highly anticipated 5th Annual Audio Description Awards Gala. Set to take place in November 2025, this event promises to be a dazzling showcase of talent, creativity, and inclusivity within the media landscape. With a focus on...

Continue Reading
The Alkaline Water Company Expands Its Reach in the Midwest

Updated Category News Views 177

The Alkaline Water Company's Growth in the Midwest Market The Alkaline Water Company, Inc. (OTC: WTER), a prominent name in the beverage industry, is making waves with its latest expansion efforts. With a focus on providing high-quality purified alkaline water enhanced with Himalayan rock salt, the company has recently partnered with Pete's Market, a well-respected...

Continue Reading
SELLAS Life Sciences Doses First Pediatric AML Patient in Trial

Updated Category News Views 177

SELLAS Life Sciences Takes a Major Step in Pediatric AML Treatment SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) has reached a significant milestone by dosing the first pediatric patient in their ongoing Phase 2 trial of SLS009, a groundbreaking treatment aimed at relapsed/refractory acute myeloid leukemia (r/r AML). This development marks a notable advancement in their...

Continue Reading
Almara Women's Health Revolutionizes Care for Women Everywhere

Updated Category News Views 407

Almara Women's Health Launches Innovative Whole-Woman Care Uniting Seven Twin Cities Practices Under One Vision Almara Women's Health is introducing a groundbreaking model of care specifically designed for women of all ages. This newly unified collaboration of healthcare providers is set to transform the way women experience healthcare, ensuring that all aspects of their...

Continue Reading
Exploring the Growing Influence of Marketing Platforms Today

Updated Category News Views 115

The Surge of Influencer Marketing Platforms The global influencer marketing platform market is on a significant upward trajectory. This dynamic industry is projected to expand from USD 10.6 billion in 2023 to USD 14.2 billion in just one year, ultimately reaching a colossal USD 50.3 billion by 2028. Such extraordinary growth indicates a CAGR of 37.1% from 2024 to 2028....

Continue Reading